About Us
Julie Barnes, PhD., Founding CEO and Chief Scientific Officer

Julie Barnes, PhD.

  • Founding CEO and Chief Scientific Officer

Julie has over 30 years of experience in Life Sciences, working in both public and private companies.  She spent 15 years in pharmaceutical R&D, latterly with GlaxoSmithKline as Head of Neuroscience (1996-2001).  Since then she has assumed several roles in small venture-backed companies active in software, medical device development and drug development, where she has lead scientific, regulatory and commercial strategy. In 2013, she won the WISE (Women in Science and Engineering) Award for Enterprise and Innovation.

Chris Poole

Chris Poole

  • Chief Financial Officer

Chris has over 25 years’ experience in finance and has held senior positions at a variety of organization types, ranging from business start-ups to a FTSE 250 company. He joined Abcodia as CFO in October 2015. Before joining the company Chris was CFO at Zinwave Ltd, steering the company to its sale in 2014. He was the Finance Director at Enecsys Ltd. and played a fundamental role in numerous fund raising activities, (including Series B for $41m) to support the global growth of the organization.

Kate Rowley

  • Chief Business Officer

Kate has over 25 years of life science experience working in both the public and private healthcare sectors. For the last 8 years she has worked specifically in investment; leading investments and serving on the boards of early stage companies in the life sciences and med tech sectors. Kate has held a diverse number of roles from initiating and growing start up diagnostics companies to leading Business Development in Europe for a multinational business. Much of Kate’s time has been spent driving commercial activities and developing commercial strategies in order to grow businesses.

David Millard

  • Global Head, Information Technology

David has 25 years of experience leading Information Technology in life science companies with products including Stem Cell Banking, Human Genomics, and both software and hardware based Medical Devices.  He has worked in early-stage commercial organizations, those making the transition from clinical to commercial strategies through IPO and acquisition, as well as PerkinElmer, a Fortune 1000 global healthcare company.